These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The value of plasma estrogen estimations in the management of pregnancy. Brown JB Clin Perinatol; 1974 Sep; 1(2):273-91. PubMed ID: 4620151 [No Abstract] [Full Text] [Related]
4. Effect of the oxytocin challenge test on levels of maternal serum unconjugated serum estriol and estetrol pre- and post-test in high-risk pregnancies. Sampson MB; Kundu N; Peterson LP Am J Perinatol; 1986 Jan; 3(1):22-3. PubMed ID: 3942609 [No Abstract] [Full Text] [Related]
5. Maternal plasma free oestriol and 24 hour urinary oestriol excretion in the assessment of foetal outcome. Unnérus HA Acta Endocrinol Suppl (Copenh); 1979; 226():3-80. PubMed ID: 289271 [No Abstract] [Full Text] [Related]
6. [Oestrogen metabolism in pregnant women]. Bjoro K Tidsskr Nor Laegeforen; 1972 Oct; 92(29):1926-8. PubMed ID: 4264097 [No Abstract] [Full Text] [Related]
7. Comparison between serum estriol and urinary estrogens as indices of fetoplacental function. Ylikorkala O; Haapalahti J; Jouppila P Arch Gynakol; 1976 Oct; 221(3):179-85. PubMed ID: 990060 [TBL] [Abstract][Full Text] [Related]
8. Daily antenatal cardiotocography in the management of high-risk pregnancies. Weiss DB; Pugh C; Simmons SC Int Surg; 1977 Sep; 62(9):470-5. PubMed ID: 908631 [No Abstract] [Full Text] [Related]
9. Prediction of fetal outcome by urinary estriol, maternal serum placental lactogen, and alpha-fetoprotein in diabetes and hepatosis of pregnancy. Garoff L Obstet Gynecol; 1976 Dec; 48(6):659-66. PubMed ID: 63107 [TBL] [Abstract][Full Text] [Related]
10. [Feto-placental unit and estriol]. Akasu F; Nakayama T; Yoshida T; Kamata S; Kanbegawa A Nihon Sanka Fujinka Gakkai Zasshi; 1970 Aug; 22(8):887-96. PubMed ID: 5530135 [No Abstract] [Full Text] [Related]
11. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy]. Gherzi R; Pastore M; Labate D Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213 [No Abstract] [Full Text] [Related]
12. Endocrinology of the maternal-fetoplacental unit. I. Use of serum estrogens as a practical index of fetal well-being. Boots L; Younger JB; Mullis JW; Beck LR Am J Obstet Gynecol; 1974 Oct; 120(4):515-23. PubMed ID: 4413233 [No Abstract] [Full Text] [Related]
13. [Determination of urinary estriol in screening fetal distress in utero]. Morin P; Abbou S Gynecol Obstet (Paris); 1970; 69(1):35-42. PubMed ID: 5438791 [No Abstract] [Full Text] [Related]
14. [Study of estrogen in the fetus, placenta and the maternal body]. Saito S Nihon Sanka Fujinka Gakkai Zasshi; 1968 Apr; 20(4):358-64. PubMed ID: 5748481 [No Abstract] [Full Text] [Related]
16. [Modern hormonal methods used in the diagnosis of fetal distress]. Markovski N; Trepechov S; Zhekova V Akush Ginekol (Sofiia); 1977; 16(4):267-73. PubMed ID: 333973 [No Abstract] [Full Text] [Related]
17. Principles of managing the high-risk pregnant patient. Zoller DP Am Fam Physician; 1983 Jan; 27(1):216-21. PubMed ID: 6823794 [TBL] [Abstract][Full Text] [Related]
18. [Pregnancies of high fetal risk. II. Evolution of fetoplacental function in intrahepatic cholestasis in pregnancy by means of urinary excretion of estriol]. Espinoza J; Barnafi L; Gormaz G; Manubens F Rev Chil Obstet Ginecol; 1975; 40(4):203-11. PubMed ID: 1233548 [No Abstract] [Full Text] [Related]
19. [Cardiotocographic findings during amniocentesis in monitoring high-risk pregnancies]. Paladini A; Di Lieto A; Rullo F; Catalano D Minerva Ginecol; 1980 Oct; 32(10):881-6. PubMed ID: 7432698 [No Abstract] [Full Text] [Related]
20. [Diseases of the mother, pregnancy complications and fetal risk - possibilities of prognosis]. Pontuch A Cesk Gynekol; 1980 Jun; 45(5):322-7. PubMed ID: 7397840 [No Abstract] [Full Text] [Related] [Next] [New Search]